Bcal Diagnostics Limited has released a press release.
BCAL Takes Interest in Genetic Signatures to 18.46%
Earlier from Bcal Diagnostics
- BCAL Secures Funding for FY2027 Update
- BCAL to Acquire Shares in Genetic Signatures
- BCAL Secures Funding for FY2027
- BCAL Develops New Blood Test for Breast Cancer Recurrence